儿童骨肿瘤肱骨近端重建中表面置换同种异体骨-假体复合物的无翻修生存率如何
BACKGROUND: Reconstruction of the proximal humerus in children who undergo bone tumor resection is challenging because of patients' small bone size and possible limb length discrepancy at the end of skeletal growth due to loss of the physis.…
要点
- 18例患儿中4例因同种异体骨吸收或骨折行翻修,3年重建失败率为25%。
- 17例随访超过2年者末次随访中位肌肉骨骼肿瘤协会功能评分为23/30。
- 作者推荐使用长柄表面置换同种异体骨-假体复合物,可能降低并发症风险。
核心结论
- 表面置换同种异体骨-假体复合物并发症风险高,但并非所有并发症均导致移植物取出。
- 作者认为该技术可用于骨量小的极年幼儿童及行腋神经保留的较大儿童,作为保留骨量并获得良好功能结果的替代手术选择。
- 作者推荐使用长柄表面置换同种异体骨-假体复合物,可能降低并发症风险。
研究设计与样本
- 回顾性单臂病例分析,单中心,2003年至2021年收治的100例肱骨骨肿瘤患儿中,18例(占潜在合格者的26%)接受表面置换同种异体骨-假体复合物重建。
- 纳入标准为肱骨近端干骺端恶性骨肿瘤、无关节污染证据且可保留腋神经的儿童;9例使用长柄(≥6 cm),9例使用短柄(<6 cm)。
- 18例中9例男孩、9例女孩,诊断时中位年龄10岁(范围4至15岁);1例随访不足2年,其余17例中位随访4.7年(范围2至19年)。
主要发现
- 竞争风险分析显示3年重建失败率为25%(95%CI 7%至40%),之后达到平台期。
- 18例中4例因近端同种异体骨吸收(2例)或同种异体骨骨折(2例)行手术翻修;短柄组9例中3例翻修,长柄组9例中1例翻修。
- 18例中4例观察到同种异体骨吸收但未行额外手术,4例肩关节不稳或半脱位但仅1例行反向肩关节置换术而未取出复合物。
- 17例随访超过2年者末次随访中位肌肉骨骼肿瘤协会功能评分为23/30(范围20至26);1例优(≥26分),15例良(21至25分),1例可(≤20分)。
- 肩关节中位屈曲角度为40°(范围20°至90°),中位外展角度为30°(范围20°至90°)。
临床怎么用
- 作者认为表面置换同种异体骨-假体复合物可作为极年幼儿童保留骨量并获得良好功能结果的替代手术选择。
- 作者推荐使用长柄表面置换同种异体骨-假体复合物,可能降低并发症风险。
局限性
- 本研究为回顾性、单臂、单中心的小样本病例系列(18例)。
- 18例中1例随访不足2年。
- 作者指出该技术成功可能因并发症风险高而受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reconstruction of the proximal humerus in children who undergo bone tumor resection is challenging because of patients' small bone size and possible limb length discrepancy at the end of skeletal growth due to loss of the physis. There are several options for proximal humerus reconstruction in children, such as clavicula pro humero, free vascularized fibula grafting, massive bone osteoarticular allografting, endoprostheses, and allograft-prosthesis composites, but no consensus exists on the best method for reconstruction. Resurfaced allograft-prosthesis composites could be an alternative surgical option, but little is known about the results of this surgical technique. QUESTIONS/PURPOSES: (1) What are the complications and what is the survivorship free from reconstruction failure associated with resurfaced allograft-prosthesis composites in a small, single-center case series? (2) What Musculoskeletal Tumor Society scores do patients achieve after reconstructions with resurfaced allograft-prosthesis composites? METHODS: This study was a retrospective, single-arm case analysis in a single institution. We generally considered resurfaced allograft-prosthesis composites in children with malignant bone tumors involving the metaepiphysis of the proximal humerus in whom there was no evidence of joint contamination and in whom axillary nerve preservation was possible. Between 2003 and 2021, we treated 100 children (younger than 15 years) with bone tumors of the humerus. Thirty children (30%) with diaphyseal tumors (21 children) or distal tumors (9 children) were excluded. Among the potentially eligible children, 52 were not analyzed because they were treated with other procedures such as amputation, modular prostheses, cement spacers, free vascularized fibula grafting, and massive bone osteoarticular allografts. We included 18 children (26% of the potentially eligible children) who were treated with resurfaced allograft-prosthesis composites. There were 9 boys and 9 girls, with a median age of 10 years (range 4 to 15 years) at the time of diagnosis. A long stem (≥ 6 cm) in the resurfaced allograft-prosthesis composite was used in 9 children and a short stem (< 6 cm) was used in the remaining 9. One of the 18 children had a follow-up of less than 2 years. The median follow-up of the remaining 17 children was 4.7 years (range 2 to 19 years). The children' medical records were reviewed for clinical and functional outcomes. We performed a competing risk analysis to calculate the reconstruction failure-free survival of resurfaced allograft-prosthesis composites. Reconstruction failure was defined as removal of the implant or allograft because of implant loosening or breakage and allograft fracture or resorption. We analyzed the children's postoperative complications and functional outcomes at the end of the follow-up period using the Musculoskeletal Tumor Society functional scoring system. RESULTS: The competing risk analysis revealed that reconstruction failure was 25% (95% confidence interval 7% to 40%) at 3 years, reaching a plateau. Four of 18 children underwent surgical revision with a new reconstruction. The reasons for reconstruction revision were resorption of the allograft at the proximal part (2 children) and fracture of the allograft (2 children). Reconstruction revision was performed in 3 of 9 children who underwent reconstruction with a short stem and in 1 of 9 children who underwent reconstruction with a long stem. Several children had other complications that did not result in removal of the allograft. Allograft resorption was observed in 4 of 18 children, but no additional surgical treatment was performed. Shoulder instability or subluxation was observed in 4 of 18 children, but only 1 child underwent surgery with a reverse shoulder arthroplasty without removal of the resurfaced allograft-prosthesis composite. Limited elbow motion because of plate impingement was observed in 1 child who underwent surgical cutting of the protruding distal part of the plate. Incomplete radial nerve palsy after surgery occurred in 1 child, with spontaneous resolution after 2 months. Screw loosening occurred in 2 children who underwent surgery with removal of loose screws. Two children had a nonunion at the graft-host bone junction; 1 child underwent surgery with bone grafting and refixation of the graft-host bone junction, and the other child with both nonunion and plate breakage was treated with bone grafting and refixation of the graft-host bone junction with a new plate. Among 17 children who had a follow-up longer than 2 years, the median Musculoskeletal Tumor Society functional score at the last follow-up interval was 23 of 30 (range 20 to 26); 1 child was considered to have an excellent result (functional score ≥ 26), 15 children were considered to have a good result (functional score 21 to 25), and 1 child was considered to have a fair result (functional score ≤ 20). The Musculoskeletal Tumor Society functional score did not change after excluding 4 children who underwent replacement of resurfaced allograft-prosthesis composites (24 of 30 [range 20 to 26]). The median angle of flexion of the shoulder was 40° (range 20º to 90°), and the median angle of abduction was 30° (range 20º to 90°). CONCLUSION: Resurfaced allograft-prosthesis composites showed a high risk of complications, but not all complications resulted in removal of the reconstructed allograft. We used this technique mainly for very young children with small bones and for older children who underwent axillary nerve preservation. Although its success may be limited owing to a high risk of complications, a resurfaced allograft-prosthesis composite could be an alternative surgical option in order to preserve the bone stock and achieve good functional outcomes in very young children. We recommend using a long-stem resurfaced allograft-prosthesis composite, which may reduce the risk of complications. LEVEL OF EVIDENCE: Level IV, therapeutic study.
引用
- Errani C, Aiba H, Atherley A, et al. What Is the Revision-free Survival of Resurfaced Allograft-prosthesis Composites for Proximal Humerus Reconstruction in Children With Bone Tumors? Clin Orthop Relat Res. 2024. PMID: 38259160. doi:10.1097/CORR.0000000000002969
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。